In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis
Abstract A single‐dose oral granule formulation of secnidazole 2 g (SOLOSEC™) has been approved in the US as a treatment for bacterial vaginosis. Available data on the likelihood of in vitro drug‐drug and alcohol‐drug interactions are limited. Secnidazole was incubated with cultured human hepatocyte...
Main Authors: | Helen S. Pentikis, Nikki Adetoro, Gregory Kaufman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.634 |
Similar Items
-
Secnidazole for treatment of bacterial vaginosis: a systematic review
by: Mohamed A. Abd El Aziz, et al.
Published: (2019-10-01) -
Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge: Bogotá, Colombia
by: Edith Ángel-Müller, et al.
Published: (2014-03-01) -
Bioavailability of two oral formulas of secnidazole in healthy volunteers
by: Patrícia Andréa Bertuol Montovani, et al.
Published: (2009-12-01) -
Antibiotic sensitivity on pathogenic bacteria causing bacterial vaginosis
by: Shiwi Linggarjati, et al.
Published: (2021-04-01) -
Single dose of secnidazole treatment against naturally occuring Giardia duodenalis infection in Sakiz lambs
by: Kerem Ural, et al.
Published: (2014-03-01)